Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review

Heart Fail Rev. 2025 Jan;30(1):227-246. doi: 10.1007/s10741-024-10458-y. Epub 2024 Nov 6.

Abstract

Adrenal insufficiency (AI) is a disorder in which inadequate glucocorticoid and mineralocorticoid hormone production leads to a variety of symptoms, including fatigue, weight loss, and nausea. In some patients with unknown AI, adrenal crisis-induced cardiogenic shock (ACCS) can be the first presentation, resulting in a fatal situation. The ACCS may exhibit unresponsiveness to inotropes and fluid therapy; thus, glucocorticoid administration is the primary vital intervention, making early detection of AI essential. Hence, in this study, we review the case reports demonstrating acute cardiomyopathies in the context of AI. The review addresses the suggested underlying mechanisms, including the diminished protective effects of glucocorticoids against catecholamines in AI. We also highlighted some clues to aid physicians in considering AI as a differential diagnosis in critically ill patients presenting cardiogenic shock.

Keywords: Adrenal crisis; Adrenal insufficiency; Cardiogenic shock; Hormone deficiency; Shock.

Publication types

  • Review

MeSH terms

  • Adrenal Insufficiency* / complications
  • Adrenal Insufficiency* / diagnosis
  • Adrenal Insufficiency* / etiology
  • Diagnosis, Differential
  • Glucocorticoids / therapeutic use
  • Humans
  • Shock, Cardiogenic* / etiology
  • Shock, Cardiogenic* / therapy

Substances

  • Glucocorticoids